Assembly Biosciences, Inc. Earnings Per Share, Basic and Diluted
Assembly Biosciences, Inc. (ASMB) reported Earnings Per Share, Basic and Diluted of -$0.48 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Assembly Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.48.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$1.34.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.41.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.69.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for fiscal 2021 was -$3.00.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.75.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for fiscal 2019 was -$3.72.
- Assembly Biosciences, Inc. earnings per share, basic and diluted for fiscal 2018 was -$3.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.48 10-Q · filed 2022-05-12 | -$1.79 derived: net income ÷ weighted average shares · filed 2023-05-04 | -$2.21 derived: net income ÷ weighted average shares · filed 2023-05-04 | |||||
| 2021-12-31 | -$1.34 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.75 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$3.00 10-K · filed 2022-03-11 | |||||
| 2021-09-30 | -$0.41 10-Q · filed 2021-11-04 | -$1.63 10-Q · filed 2021-11-04 | ||||||
| 2021-03-31 | -$0.69 10-Q · filed 2022-05-12 | -$1.77 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$1.89 derived: net income ÷ weighted average shares · filed 2022-05-12 | |||||
| 2020-12-31 | -$1.10 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$1.20 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$1.75 10-K · filed 2022-03-11 | |||||
| 2020-09-30 | -$0.09 10-Q · filed 2021-11-04 | -$0.64 10-Q · filed 2021-11-04 | ||||||
| 2020-03-31 | -$0.76 10-Q · filed 2021-05-06 | -$1.71 derived: net income ÷ weighted average shares · filed 2021-05-06 | -$2.66 derived: net income ÷ weighted average shares · filed 2021-05-06 | -$3.40 derived: net income ÷ weighted average shares · filed 2021-05-06 | ||||
| 2019-12-31 | -$0.99 10-K · filed 2021-02-25 | -$1.94 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.67 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.72 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$0.96 10-K · filed 2021-02-25 | -$1.68 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.74 10-Q · filed 2020-11-05 | -$3.76 derived: net income ÷ weighted average shares · filed 2021-02-25 | ||||
| 2019-06-30 | -$0.72 10-K · filed 2021-02-25 | -$1.77 10-Q · filed 2019-08-05 | -$2.80 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.66 derived: net income ÷ weighted average shares · filed 2021-02-25 | ||||
| 2019-03-31 | -$1.05 10-K · filed 2021-02-25 | -$2.08 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.95 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.21 derived: net income ÷ weighted average shares · filed 2021-02-25 | ||||
| 2018-12-31 | -$1.03 10-K · filed 2020-03-04 | -$1030.00 10-K · filed 2019-02-28 | -$1.89 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.15 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.98 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$0.87 10-K · filed 2020-03-04 | -$2.13 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$2.95 10-Q · filed 2019-11-07 | -$3.19 derived: net income ÷ weighted average shares · filed 2020-03-04 | ||||
| 2018-06-30 | -$1.30 10-K · filed 2020-03-04 | -$2.11 10-Q · filed 2019-08-05 | -$2.31 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$3.02 derived: net income ÷ weighted average shares · filed 2020-03-04 | ||||
| 2018-03-31 | -$0.80 10-K · filed 2020-03-04 | -$0.98 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$1.67 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$2.44 derived: net income ÷ weighted average shares · filed 2020-03-04 | ||||
| 2017-12-31 | -$160.00 10-K · filed 2019-02-28 | -$0.16 10-K · filed 2018-03-08 | -$0.84 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$1.61 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$2.41 10-K · filed 2020-03-04 | |||
| 2017-09-30 | -$710.00 10-K · filed 2019-02-28 | -$0.71 10-Q · filed 2017-11-01 | -$1.49 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.30 10-Q · filed 2018-11-08 | -$2.97 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||
| 2017-06-30 | -$780.00 10-K · filed 2019-02-28 | -$0.78 10-Q · filed 2017-08-09 | -$1.59 10-Q · filed 2018-08-08 | -$2.26 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.93 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||
| 2017-03-31 | -$810.00 10-K · filed 2019-02-28 | -$0.81 10-Q · filed 2017-05-08 | -$1.48 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.15 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.74 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||
| 2016-12-31 | -$0.67 10-K · filed 2018-03-08 | -$1.34 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.93 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.57 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$0.67 10-K · filed 2018-03-08 | -$1.26 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.90 10-Q · filed 2017-11-01 | -$2.35 derived: net income ÷ weighted average shares · filed 2018-03-08 | ||||
| 2016-06-30 | -$0.59 10-K · filed 2018-03-08 | -$1.23 10-Q · filed 2017-08-09 | -$1.68 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$2.06 derived: net income ÷ weighted average shares · filed 2018-03-08 | ||||
| 2016-03-31 | -$0.64 10-K · filed 2018-03-08 | -$1.09 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.47 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.88 derived: net income ÷ weighted average shares · filed 2018-03-08 | ||||
| 2015-12-31 | -$0.45 10-K · filed 2017-03-02 | -$0.83 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.24 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.81 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | -$0.38 10-K · filed 2017-03-02 | -$0.79 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$1.36 10-Q · filed 2016-11-09 | -$1.92 derived: net income ÷ weighted average shares · filed 2017-03-02 | ||||
| 2015-06-30 | -$0.41 10-K · filed 2017-03-02 | -$0.99 10-Q · filed 2016-08-09 | -$1.57 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$2.66 derived: net income ÷ weighted average shares · filed 2017-03-02 | ||||
| 2015-03-31 | -$0.64 10-K · filed 2017-03-02 | -$1.23 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$2.44 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$3.10 derived: net income ÷ weighted average shares · filed 2017-03-02 | ||||
| 2014-12-31 | -$0.59 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$1.83 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$2.51 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$3.40 10-K · filed 2017-03-02 | ||||
| 2014-09-30 | -$1.33 10-Q · filed 2015-11-09 | -$2.08 derived: net income ÷ weighted average shares · filed 2015-11-09 | -$3.02 10-Q · filed 2015-11-09 | -$4.38 derived: net income ÷ weighted average shares · filed 2015-11-09 | ||||
| 2014-06-30 | -$0.52 10-Q · filed 2015-08-13 | -$1.43 10-Q · filed 2015-08-13 | -$2.84 derived: net income ÷ weighted average shares · filed 2015-08-13 | -$4.04 derived: net income ÷ weighted average shares · filed 2015-08-13 | ||||
| 2014-03-31 | -$0.92 10-Q · filed 2015-05-08 | -$0.18 10-Q · filed 2014-05-14 | -$2.35 derived: net income ÷ weighted average shares · filed 2015-05-08 | -$3.58 derived: net income ÷ weighted average shares · filed 2015-05-08 | -$4.78 derived: net income ÷ weighted average shares · filed 2015-05-08 | |||
| 2013-12-31 | -$1.45 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$2.68 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$3.89 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$5.00 10-K · filed 2015-03-16 | -$1.00 10-K · filed 2014-03-31 | |||
| 2013-09-30 | -$1.23 10-Q · filed 2014-11-17 | -$0.25 10-Q · filed 2013-11-12 | -$2.43 derived: net income ÷ weighted average shares · filed 2014-11-17 | -$3.53 10-Q · filed 2014-11-17 | -$0.71 10-Q · filed 2013-11-12 | -$1.81 derived: net income ÷ weighted average shares · filed 2014-11-17 | ||
| 2013-06-30 | -$1.20 10-Q · filed 2014-08-14 | -$0.24 10-Q · filed 2013-08-09 | -$2.30 10-Q · filed 2014-08-14 | -$0.46 10-Q · filed 2013-08-09 | -$1.08 derived: net income ÷ weighted average shares · filed 2014-08-14 | -$1.50 derived: net income ÷ weighted average shares · filed 2014-08-14 | ||
| 2013-03-31 | -$0.22 10-Q · filed 2014-05-14 | -$0.50 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$0.90 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$1.46 derived: net income ÷ weighted average shares · filed 2014-05-14 | ||||
| 2012-12-31 | -$0.29 10-K · filed 2013-03-18 | -$0.71 derived: net income ÷ weighted average shares · filed 2014-03-31 | -$1.29 derived: net income ÷ weighted average shares · filed 2014-03-31 | -$1.94 10-K · filed 2014-03-31 | ||||
| 2012-09-30 | -$0.41 10-Q · filed 2013-11-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2013-11-12 | -$1.66 10-Q · filed 2013-11-12 | -$3.16 derived: net income ÷ weighted average shares · filed 2013-11-12 | ||||
| 2012-06-30 | -$0.59 10-Q · filed 2013-08-09 | -$1.25 10-Q · filed 2013-08-09 | -$2.76 derived: net income ÷ weighted average shares · filed 2013-08-09 | -$3.28 derived: net income ÷ weighted average shares · filed 2013-08-09 | ||||
| 2012-03-31 | -$0.66 10-Q · filed 2013-05-10 | -$2.18 derived: net income ÷ weighted average shares · filed 2013-05-10 | -$2.70 derived: net income ÷ weighted average shares · filed 2013-05-10 | -$3.65 derived: net income ÷ weighted average shares · filed 2013-05-10 | ||||
| 2011-12-31 | -$1.52 10-K · filed 2013-03-18 | -$2.05 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$3.04 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$3.57 10-K · filed 2013-03-18 | ||||
| 2011-09-30 | -$0.50 10-K · filed 2013-03-18 | -$1.36 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$1.79 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | -$0.97 10-K · filed 2013-03-18 | -$1.35 10-Q · filed 2012-08-09 | ||||||
| 2011-03-31 | -$0.38 10-K · filed 2013-03-18 | |||||||
| 2010-12-31 | -$24.67 10-K · filed 2013-03-18 | |||||||
| 2010-09-30 | -$3.97 10-Q/A · filed 2011-11-18 | -$13.24 10-Q/A · filed 2011-11-18 | ||||||
| 2010-06-30 | -$4.76 10-Q · filed 2011-08-15 | -$9.27 10-Q · filed 2011-08-15 | ||||||
| 2009-12-31 | -$10.02 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |